Most important, it has already been shown that T-cell activation against CD33-expressing cells, using the bsAb of this study, does not impair hematopoietic engraftment in NOD scid gamma knockout mice,23 but leads to efficient eradication of AML blasts both in vitro and in vivo. The gene discussed is CD33; the disease is acute myeloid leukemia.